Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Complement inhibitor eculizumab in thrombotic microangiopathy: Single‐center case series

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • بيانات النشر:
      Wiley, 2022.
    • الموضوع:
      2022
    • Collection:
      LCC:Medicine
      LCC:Medicine (General)
    • نبذة مختصرة :
      Abstract Our case series showed that eculizumab is efficacious and safe in treating thrombotic microangiopathy, as well as it has positive effects on quality of life. Further extensive studies are required to develop unified treatment guidelines.
    • File Description:
      electronic resource
    • ISSN:
      2050-0904
    • Relation:
      https://doaj.org/toc/2050-0904
    • الرقم المعرف:
      10.1002/ccr3.5573
    • الرقم المعرف:
      edsdoj.7a9d35369a144469b3537af2f4b748e6